secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001645113-24-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovoCure's METIS phase 3 trial data in brain metastases to be presented at ASCO 2024
--------------------------------------------------------------------------------

- Abstract for METIS phase 3 trial in brain metastases from NSCLC available May 23 on ASCO website.
- Oral presentation scheduled for June 3 at 10:24 AM CDT during CNS Tumors session.
- No data disclosed yet; trial results are pending presentation at ASCO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511324000015/0001645113-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511324000015/nvcr-20240520.htm
  HTML page:      https://secwatch.observer/filing/0001645113-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer